SCHEMBL7008412

SCHEMBL7008412

C/C(=C\c1cccc(Cl)c1Cl)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
AKR1C3 P42330 1/20 0.48
TSHR P16473 1/20 0.44
APEX1 P27695 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
PTGS2 P35354 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
PPP1R15A O75807 1/20 0.40
MELK Q14680 1/20 0.40
PPP1R15B Q5SWA1 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7008421 1.00 KMT2A (0.52) KMT2AMEN1AKR1C3TSHRAPEX1
SCHEMBL1627492 0.85 AKR1C3 (0.57) KMT2AMEN1AKR1C3APEX1ALDH1A1
SCHEMBL1627491 0.85 AKR1C3 (0.57) KMT2AMEN1AKR1C3APEX1ALDH1A1
SCHEMBL3958270 0.84 AKR1C3 (0.46) KMT2AMEN1AKR1C3TSHRAPEX1
SCHEMBL1805524 0.84 AKR1C3 (0.46) KMT2AMEN1AKR1C3TSHRAPEX1
SCHEMBL819819 0.83 KMT2A (0.44) KMT2AMEN1TSHRSMN1; SMN2ALDH1A1
SCHEMBL822890 0.83 KMT2A (0.44) KMT2AMEN1TSHRSMN1; SMN2ALDH1A1
SCHEMBL822823 0.80 KMT2A (0.47) KMT2AMEN1TSHRSMN1; SMN2ALDH1A1
SCHEMBL7820417 0.79 AKR1C3 (0.53) KMT2AMEN1AKR1C3TSHRAPEX1
SCHEMBL7820420 0.79 AKR1C3 (0.53) KMT2AMEN1AKR1C3TSHRAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed
EP-1309551-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-05-14 EP disclosed
WO-2002014273-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-02-21 WO disclosed